Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Shatsky

Showing results (1-10 of 11) with videos related to

Pageof 2
Sort By:
Blood|August 1, 1988
The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascadeS Burdach, M Shatsky, B Wagenhorst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2S Burdach, M Shatsky, B Wagenhorst, et al.
The Journal of Biological Chemistry|May 15, 1989
Interaction of histidine-rich glycoprotein with human T lymphocytesK Saigo, M Shatsky, L J Levitt, et al.
Proceedings. International Conference on Intelligent Systems for Molecular Biology|September 8, 2000
Alignment of flexible protein structuresM Shatsky, Z Y Fligelman, R Nussinov, et al.
The Journal of Biological Chemistry|May 15, 1989
Histidine-rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immunoregulationM Shatsky, K Saigo, S Burdach, et al.
The Journal of Clinical Investigation|June 1, 1991
Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptorS Burdach, N Zessack, D Dilloo, et al.
The Journal of Clinical Investigation|July 1, 1991
Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptorL J Levitt, A Nagler, F Lee, et al.
The Journal of Biological Chemistry|March 15, 1992
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytesJ L Zehnder, K Hirai, M Shatsky, et al.
Cancer Research|December 1, 1984
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell linesS D Smith, M Shatsky, P S Cohen, et al.
Blood|March 1, 1995
Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptideJ L Zehnder, M Shatsky, L L Leung, et al.
Pageof 2

Showing results (1-10 of 11) with videos related to

Sort By:
Pageof 2
Blood|August 1, 1988
The T-cell CD2 determinant mediates inhibition of erythropoiesis by the lymphokine cascadeS Burdach, M Shatsky, B Wagenhorst, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 15, 1987
Receptor-specific modulation of myelopoiesis by recombinant DNA-derived interleukin 2S Burdach, M Shatsky, B Wagenhorst, et al.
The Journal of Biological Chemistry|May 15, 1989
Interaction of histidine-rich glycoprotein with human T lymphocytesK Saigo, M Shatsky, L J Levitt, et al.
Proceedings. International Conference on Intelligent Systems for Molecular Biology|September 8, 2000
Alignment of flexible protein structuresM Shatsky, Z Y Fligelman, R Nussinov, et al.
The Journal of Biological Chemistry|May 15, 1989
Histidine-rich glycoprotein blocks T cell rosette formation and modulates both T cell activation and immunoregulationM Shatsky, K Saigo, S Burdach, et al.
The Journal of Clinical Investigation|June 1, 1991
Differential regulation of lymphokine production by distinct subunits of the T cell interleukin 2 receptorS Burdach, N Zessack, D Dilloo, et al.
The Journal of Clinical Investigation|July 1, 1991
Production of granulocyte/macrophage-colony-stimulating factor by human natural killer cells. Modulation by the p75 subunit of the interleukin 2 receptor and by the CD2 receptorL J Levitt, A Nagler, F Lee, et al.
The Journal of Biological Chemistry|March 15, 1992
The cell adhesion molecule CD31 is phosphorylated after cell activation. Down-regulation of CD31 in activated T lymphocytesJ L Zehnder, K Hirai, M Shatsky, et al.
Cancer Research|December 1, 1984
Monoclonal antibody and enzymatic profiles of human malignant T-lymphoid cells and derived cell linesS D Smith, M Shatsky, P S Cohen, et al.
Blood|March 1, 1995
Involvement of CD31 in lymphocyte-mediated immune responses: importance of the membrane-proximal immunoglobulin domain and identification of an inhibiting CD31 peptideJ L Zehnder, M Shatsky, L L Leung, et al.
Pageof 2